Patriot Financial Group Insurance Agency’s Corcept Therapeutics CORT Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24	Closed	-$1K	–	704
2022 Q2	$1K	Hold	24	–	–	﹤0.01%	1873
2022 Q1	$1K	Hold	24	–	–	﹤0.01%	1927
2021 Q4	$0	Hold	24	–	–	﹤0.01%	2159
2021 Q3	$0	Hold	24	–	–	﹤0.01%	2156
2021 Q2	$1K	Hold	24	–	–	﹤0.01%	1965
2021 Q1	$1K	Hold	24	–	–	﹤0.01%	1865
2020 Q4	$1K	Hold	24	–	–	﹤0.01%	1731
2020 Q3	$0	Hold	24	–	–	﹤0.01%	1690
2020 Q2	$0	Sell	24 -23	-49%	-$323	﹤0.01%	1673
2020 Q1	$1K	Buy	+47	New	+$582	﹤0.01%	1408

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Patriot Financial Group Insurance Agency's CORT Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Corcept Therapeutics (CORT) in Q3 2022, closing a stake of 24 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in CORT in Q1 2020 and held it in 10 quarters. The position peaked at $1K in Q2 2022. 239 funds tracked by Wall St. Rank hold CORT as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Corcept Therapeutics position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 24 Corcept Therapeutics shares in Q3 2022, an estimated $1K.
Patriot Financial Group Insurance Agency first reported a position in Corcept Therapeutics in Q1 2020 and held it in 10 quarters.
Patriot Financial Group Insurance Agency's Corcept Therapeutics position peaked at $1K in Q2 2022.
239 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.